Subcutaneous Immunoglobulin (Scig) Injection 20%, 10 mL/ampoule Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 20%, 10 mL/ampoule
Reference Brands: Hizentra, Cuvitru, Vivaglobulin(US)
Category: Plasma Products
SCIG provides pooled IgG antibodies directly into the tissue, boosting immune defense. It neutralizes pathogens, modulates immune responses, and reduces autoimmune activity. Benefits include convenient home administration, sustained antibody levels, fewer systemic side effects, improved quality of life, and consistent immune support in patients with immunodeficiency or autoimmune conditions.
Product Description:
Subcutaneous Immunoglobulin (SCIG), marketed as Hizentra, Cuvitru, and Vivaglobulin, is approved in the US by the FDA and in the EU via EMA for primary immunodeficiency and autoimmune diseases. Regulatory approval requires a comprehensive dossier including clinical efficacy, safety data, manufacturing quality, and pharmacovigilance plans. In the US, FDA review involves detailed assessment of clinical trials and manufacturing standards, while the EMA ensures compliance with regional quality and safety requirements. For expert guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Ensuring compliance is crucial for the safe, effective, and timely approval of SCIG products worldwide, supporting better patient outcomes.
Subcutaneous Immunoglobulin (Scig) Injection — third party manufacturing & bulk supply
Subcutaneous Immunoglobulin (Scig) Injection 20%, 10 mL/ampoule is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Subcutaneous Immunoglobulin (Scig) Injection is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Subcutaneous Immunoglobulin (Scig) Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Subcutaneous Immunoglobulin (Scig) Injec... →Frequently Asked Questions
Subcutaneous Immunoglobulin (SCIG) is used to treat patients with primary immunodeficiency disorders and certain immune system deficiencies. It helps strengthen the immune system by providing antibodies that protect the body from infections.
Subcutaneous Immunoglobulin is made from purified human immunoglobulin G (IgG) antibodies obtained from pooled plasma collected from healthy donors.
Common trade names include Hizentra, Cuvitru, HyQvia, Gammanorm, Cutaquig, Xembify, and Subgam.
Several pharmaceutical companies manufacture SCIG products worldwide including CSL Behring, Takeda Pharmaceutical Company, and Grifols.
The generic name is Human Normal Immunoglobulin.
Common brand names include Hizentra, Cuvitru, HyQvia, Gammanorm, Cutaquig, Xembify, and Subgam.
Subcutaneous Immunoglobulin products are manufactured in several countries including the United States, Germany, Austria, and other regions by different plasma-derived pharmaceutical manufacturers.
Related Products
Marstacimab‑Hncq
Strength:
150 mg/mL
Form: injection (prefilled syringe)
Reference Brands: Hympavzi (USA)
View Details
Emicizumab‑Kxwh
Strength:
30 mg/mL, 60 mg/0.4 mL, 105 mg/0.7 mL
Form: Injection
Reference Brands: Hemlibra (USA/EU)
View Details
Concizumab-Mtci
Strength:
60 mg/1.5 mL, 150 mg/1.5 mL, 300 mg/3 mL
Form: Prefilled autoinjector
Reference Brands: Alhemo (USA/EU)
View Details
Fresh Frozen Plasma (Ffp) Powder For Reconstitution Or Liquid
Strength:
available in 200-250 mL units
Form: liquid units or lyophilized (freeze-dried) powder
Reference Brands: No specific brands
View DetailsQuick Response Guaranteed | Verified Suppliers
